CD19-directed CAR T cells as first salvage therapy for large B-cell lymphoma: towards a rational approach-Reference-Cited by-同舟云学术

CD19-directed CAR T cells as first salvage therapy for large B-cell lymphoma: towards a rational approach

Published:2023-12 Issue:12 Volume:10 Page:e1006-e1015
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Dreger Peter,Corradini Paolo,Gribben John G,Glass Bertram,Jerkeman Mats,Kersten Marie Jose,Morschhauser Franck,Mussetti Alberto,Viardot Andreas,Zinzani Pier Luigi,Sureda Anna

Publisher

Elsevier BV

Subject

Hematology

Reference74 articles.

1. CAR T cells as a second-line therapy for large B-cell lymphoma: a paradigm shift?;Westin;Blood,2022

2. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: lymphoid neoplasms;Alaggio;Leukemia,2022

3. Lisocabtagene maraleucel versus standard of care with salvage chemotherapy followed by autologous stem cell transplantation as second-line treatment in patients with relapsed or refractory large B-cell lymphoma (TRANSFORM): results from an interim analysis of an open-label, randomised, phase 3 trial

4. Axicabtagene ciloleucel as second-line therapy for large B-cell lymphoma;Locke;N Engl J Med,2022

5. Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma;Neelapu;N Engl J Med,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytomegaloviral Infections in Recipients of Chimeric Antigen Receptor T-Cell Therapy: An Observational Study With Focus on Oncologic Outcomes;Open Forum Infectious Diseases;2024-07-18

2. CD22 CAR T-cell therapy: new hope for patients with large B-cell lymphoma;The Lancet;2024-07

3. Canadian cancer trials group LY.17: A randomized phase II study evaluating novel salvage therapy pre‐autologous stem cell transplant in relapsed/refractory diffuse large B‐cell lymphoma—outcome of rituximab‐dose‐intensive cyclophosphamide, etoposide, cisplatin (R‐DICEP) versus R‐GDP;British Journal of Haematology;2024-05-27

4. CAR T treatment beyond cancer: Hope for immunomodulatory therapy of non-cancerous diseases;Life Sciences;2024-05